Vascular calcification (VC) is frequently observed in patients with chronic renal failure and appears to be an active process involving transdifferentiation of vascular smooth muscle cells (VSMCs) to osteoblast-like cells. Reports of VC prevention in uremic rodents by calcimimetics coupled with identification of the calcium-sensing receptor (CaSR) in VSMCs led us to hypothesize that CaSR activation in arterial cells and VSMCs may elicit expression of an endogenous inhibitor of VC. Toward this end, we determined the effects of calcium and the calcimimetic AMG 641 on arterial wall and isolated VSMC expression of matrix-Gla protein (MGP). Bovine VSMCs were incubated with increasing calcium chloride or AMG 641 concentrations, while in vivo experiments were carried out on healthy and uremic rats. Both AMG 641 and hypercalcemia induced MGP expression in the arterial wall in healthy and uremic rats. The results obtained in vitro supported those from in vivo experiments. In conclusion, selective CaSR activation, either by extracellular calcium or AMG 641, increased MGP expression in vivo in the arterial wall and in vitro in bovine VSMCs. This local upregulation of MGP expression provides one potential mechanism by which calcimimetics prevent VC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00223-010-9442-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.
Kidney Int
May 2019
Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain; Nephrology Service, Reina Sofia University Hospital, Cordoba, Spain; University of Cordoba, Cordoba, Spain; Spanish Renal Research Network (REDinREN), Institute of Health Carlos III, Madrid, Spain.
Article Synopsis
- Calcimimetics lower the levels of parathyroid hormone (PTH), which can help with bone health, especially in patients with certain kidney issues.
- In experiments, calcimimetics increased the number of bone-making cells called osteoblasts and promoted bone formation in healthy and sick rats.
- These medications have a positive effect on bones by encouraging bone growth even when PTH levels are lowered.
Calcium-sensing receptor-mediated osteogenic and early-stage neurogenic differentiation in umbilical cord matrix mesenchymal stem cells from a large animal model.
PLoS One
July 2015
Department of Emergency and Organ Transplantation (DETO) - Section of Veterinary Clinics and Animal Productions, University of Bari Aldo Moro, Valenzano, Bari, Italy.
Article Synopsis
- The study explores the potential of umbilical cord matrix mesenchymal stem cells (UCM-MSCs) for therapeutic uses, specifically their differentiation into bone (osteogenic) and nerve (neurogenic) cells when influenced by the calcium-sensing receptor (CaSR).
- The research involved large and small equine UCM-MSC lines cultured in calcium-enriched mediums and treated with a CaSR agonist, AMG641, which showed a dose-dependent increase in cell proliferation and varying effects on osteogenic marker expression.
- Findings suggest that AMG641 can enhance neurogenic differentiation and that CaSR plays a critical role in regulating the differentiation processes of these stem cells.
Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action.
Cardiovasc Res
February 2014
Inserm Unit 1088, University of Picardie Jules Verne, 1 rue des Louvels, 80037 Amiens, France.
Aims: Vascular calcification (VC) contributes to morbidity and mortality in patients with chronic kidney disease (CKD). Allosteric modulators of the calcium (Ca)-sensing receptor (CaSR) may slow the progression of VC in CKD patients either by reducing serum parathyroid hormone (PTH), Ca, and phosphate levels or by a direct effect on the vessel wall. The aim of this study was to examine the effects of calcimimetics on CaSR expression, cell phenotype, and mineral deposition in human vascular smooth muscle cells (h-VSMCs).
View Article and Find Full Text PDFLocalization, distribution, and function of the calcium-sensing receptor in sperm.
J Androl
April 2012
Dept Medicina y Cirugia Animal, Universidad de Cordoba, Campus Universitario Rabanales, Ctra. Madrid-Cadiz km 396, Cordoba, Spain.
The intracellular movement of calcium, through calcium channels, plays a major role on sperm cell function. The calcium-sensing receptor (CaSR), a molecular mechanism by which many cells detect changes in extracellular calcium concentration, has not been described in spermatozoa. The aim of this study was to investigate the expression of the CaSR in testicular tissue and sperm cells and the functional consequences of spermatozoid CaSR activation by calcimimetics.
View Article and Find Full Text PDFEffect of calcium and the calcimimetic AMG 641 on matrix-Gla protein in vascular smooth muscle cells.
Calcif Tissue Int
March 2011
Departamento de Medicina y Cirugia Animal, Universidad de Cordoba, Campus Universitario Rabanales, Spain.
Vascular calcification (VC) is frequently observed in patients with chronic renal failure and appears to be an active process involving transdifferentiation of vascular smooth muscle cells (VSMCs) to osteoblast-like cells. Reports of VC prevention in uremic rodents by calcimimetics coupled with identification of the calcium-sensing receptor (CaSR) in VSMCs led us to hypothesize that CaSR activation in arterial cells and VSMCs may elicit expression of an endogenous inhibitor of VC. Toward this end, we determined the effects of calcium and the calcimimetic AMG 641 on arterial wall and isolated VSMC expression of matrix-Gla protein (MGP).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!